Sirios Capital Management L P Decreases Stake in HCA Healthcare, Inc. $HCA

10 Dec 2025, 08:14 by Scott Moore · The Cerbat Gem

Sirios Capital Management L P lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 50.0% in the 2nd quarter, Holdings Channel reports. The fund owned 16,790 shares of the company’s stock after selling 16,788 shares during the quarter. HCA Healthcare accounts for 0.9% of Sirios Capital Management L P’s holdings, making the stock its 27th largest holding. Sirios Capital Management L P’s holdings in HCA Healthcare were worth $6,432,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at about $1,152,408,000. Price T Rowe Associates Inc. MD grew its stake in shares of HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after buying an additional 1,091,416 shares during the period. Abdiel Capital Advisors LP purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at approximately $164,835,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in HCA Healthcare during the second quarter worth $109,337,000. Finally, Metropolis Capital Ltd lifted its stake in shares of HCA Healthcare by 76.6% in the 2nd quarter. Metropolis Capital Ltd now owns 603,029 shares of the company’s stock valued at $231,020,000 after purchasing an additional 261,592 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of several research analyst reports. Raymond James Financial set a $525.00 target price on shares of HCA Healthcare in a research note on Monday, October 27th. Oppenheimer upped their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. Truist Financial boosted their price objective on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a report on Monday, October 27th. Morgan Stanley set a $425.00 target price on HCA Healthcare in a research report on Monday, October 27th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $474.53.

View Our Latest Research Report on HCA

HCA Healthcare Trading Up 0.7%

Shares of HCA opened at $488.44 on Wednesday. The firm’s fifty day simple moving average is $462.50 and its 200-day simple moving average is $411.98. The firm has a market capitalization of $111.46 billion, a price-to-earnings ratio of 18.88, a PEG ratio of 1.43 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same period last year, the firm earned $4.90 earnings per share. HCA Healthcare’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by company insiders.

About HCA Healthcare

(Free Report)